查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1832516

速效氣喘治療市場報告：2031 年趨勢、預測與競爭分析

Quick-Acting Asthma Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

由於醫院藥局、線上藥局和零售藥局市場蘊藏著機遇，全球速效氣喘藥物市場前景光明。預計2025年至2031年，全球速效氣喘藥物市場的複合年成長率將達到5.1%。該市場的主要驅動力包括日益成長的醫療保健需求、慢性病盛行率的上升以及生物相似藥和非專利氣喘藥物的興起。

  • 根據 Lucintel 的預測，由於更精確的劑量控制和廣泛的採用，平板電腦預計在預測期內將實現高速成長。
  • 從應用角度來看，醫院藥房由於對配藥和庫存管理具有高度的控制力，預計將實現最大的成長。
  • 按地區分類，北美預計將在預測期內實現最高成長，因為其擁有先進的醫療保健基礎設施和日益普及的藥品。

速效氣喘藥物市場的新趨勢

速效氣喘藥物市場正經歷一系列新興趨勢，這些趨勢的驅動力包括技術進步、醫療服務模式的轉變以及氣喘盛行率的上升。這些趨勢正在重塑氣喘的治療和管理方式，為產業相關人員帶來挑戰和機會。以下是一些正在改變市場的關鍵趨勢：

  • 吸入器創新與設計：吸入器技術的進步顯著改善了患者的治療效果。呼吸驅動式吸入器和攜帶式設備日益普及，使患者能夠更輕鬆、更準確地給藥。這些創新也有助於減少用戶用藥量，進而提高服藥順從性。製造商越來越注重設計更容易使用、劑量更精準的吸入器，尤其針對兒童和老年人，改善整體氣喘管理體驗。
  • 生物相似藥和學名藥：生物相似藥和學名藥氣喘藥物的興起使得速效治療藥物更加經濟實惠，尤其是在新興市場。隨著某些關鍵氣喘藥物的專利到期，越來越多的學名藥進入市場，為品牌藥提供了經濟高效的替代方案。這一趨勢在印度和中國等地區尤其明顯，因為這些地區的醫療成本在醫療保健的可近性方面起著重要作用。因此，更多患者能夠獲得控制氣喘所需的藥物，進而改善健康狀況。
  • 數位健康整合：數位健康科技與氣喘管理的整合正日益深入。行動應用程式、智慧吸入器和遠端監控設備使患者能夠即時追蹤藥物使用情況、氣喘症狀和誘因。這些技術使醫療服務提供者能夠根據收集的患者數據量身定做治療方案，從而提供更個人化、更快捷的照護。隨著數位健康生態系統的發展，它將增強患者參與度，從而改善氣喘管理和療效。
  • 個人化醫療：個人化醫療正成為速效氣喘藥物市場的重要趨勢，它能夠根據每位患者的個別需求量身訂做治療方案。基因監測和生物標記識別技術的進步使得更精準的治療方案能夠將患者獨特的氣喘誘因和潛在遺傳因素納入考慮。這一趨勢有望提高氣喘治療的有效性，減少副作用，並為難以接受傳統治療的患者提供更有針對性的緩解。
  • 政府措施與公共衛生宣傳活動：世界各國政府日益重視氣喘管理，並進行公共衛生宣傳活動以提高公眾意識，改善氣喘治療。促進早期診斷、更優藥物治療和預防措施的政策有助於減輕氣喘的氣喘負擔。此外，全球為減少空氣污染所做的努力也有助於改善氣喘控制，減少氣喘發作。這些努力對於氣喘高發國家（例如中國和印度）尤其重要，因為政府的支持對於提高這些國家居民的醫療保健可近性至關重要。

吸入器創新、生物相似藥、數位健康整合、個人化醫療以及政府措施等新興趨勢正在重塑速效氣喘藥物市場。這些趨勢正在提高氣喘治療的可近性、有效性和可負擔性，從而改善患者的治療效果，並擴大全球市場。

速效氣喘治療市場的最新趨勢

在配方、吸入器技術和監管支援的推動下，速效氣喘藥物市場正在經歷重大的新興市場發展。這些發展使全球氣喘管理更加有效，也更加便利。以下是塑造市場的五個關鍵發展：

  • 新型複方吸入器的推出：一種新型複方吸入器，可在一台設備中同時輸送支氣管擴張劑和類固醇，正日益受到歡迎。這些吸入器提供更全面的治療，並減少了對多種藥物的需求。複方吸入器的出現使患者能夠更有效地控制氣喘症狀，從而提高治療順從性和療效。
  • 學名藥和生物類似藥的擴張：速效氣喘藥物市場正受益於學名藥和生物相似藥的推出。隨著領先的氣喘藥物專利到期，這些價格實惠的替代藥物正在擴大氣喘基本治療的可及性。學名藥正在幫助滿足日益成長的氣喘治療需求，尤其是在成本構成重大障礙的發展中地區。
  • 智慧吸入器的進步：配備數位感測器的智慧吸入器正在改變氣喘管理。這些吸入器可以追蹤使用情況，並向患者和醫護人員提供即時回饋。透過幫助使用者堅持用藥方案並追蹤症狀，智慧吸入器可以改善氣喘控制並減少住院次數。這項技術在慢性氣喘的管理以及在氣喘發作期間提供及時介入方面尤其重要。
  • 更重視兒童氣喘治療：開發兒童專用氣喘藥物正日益受到重視。兒童氣喘藥物，例如適齡吸入器和低劑量製劑，正在幫助改善兒童患者的治療效果。這些藥物的設計旨在簡化使用，並提高用藥依從性，特別適用於難以使用傳統吸入器的兒童。
  • 加速核准的監管支持：FDA 和 EMA 等監管機構擴大支持氣喘藥物的加速核准，尤其是創新治療方法。這種支持有助於加速新治療方法的獲取，並改善患者的治療選擇。簡化核准流程對於滿足全球日益成長的氣喘藥物需求以及使新藥更快進入市場至關重要。

速效氣喘藥物市場的最新發展，例如複方吸入器的推出、生物相似藥的興起、智慧吸入器技術以及支持性監管環境，正在重塑治療格局。這些創新正在改善患者護理，提高藥物的可及性，並推動市場成長。

目錄

第1章執行摘要

第2章 市場概況

  • 背景和分類
  • 供應鏈

第3章：市場趨勢及預測分析

  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

4. 全球速效氣喘治療市場（按類型）

  • 概述
  • 按類型：吸引力分析
  • 平板電腦：趨勢與預測（2019-2031）
  • 噴霧劑：趨勢與預測（2019-2031）

5. 全球速效氣喘治療市場（依應用）

  • 概述
  • 依用途：吸引力分析
  • 醫院藥局：趨勢與預測（2019-2031）
  • 網路藥局：趨勢與預測（2019-2031）
  • 零售藥局：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第6章區域分析

  • 概述
  • 按地區分類：速效氣喘藥物市場

7. 北美速效氣喘藥物市場

  • 概述
  • 北美速效氣喘治療市場（按類型）
  • 北美速效氣喘治療市場（依應用）
  • 美國速效氣喘藥物市場
  • 墨西哥速效氣喘治療市場
  • 加拿大速效氣喘藥物市場

8. 歐洲速效氣喘藥物市場

  • 概述
  • 歐洲速效氣喘藥物市場（按類型）
  • 歐洲速效氣喘治療市場（依應用）
  • 德國速效氣喘藥物市場
  • 法國速效氣喘藥物市場
  • 西班牙速效氣喘藥物市場
  • 義大利速效氣喘治療市場
  • 英國速效氣喘藥物市場

9. 亞太地區速效氣喘藥物市場

  • 概述
  • 亞太地區速效氣喘治療市場（按類型）
  • 亞太地區速效氣喘治療市場（依應用）
  • 日本速效氣喘治療市場
  • 印度速效氣喘治療市場
  • 中國速效氣喘治療市場
  • 韓國速效氣喘治療市場
  • 印尼速效氣喘藥物市場

第10章世界其他地區速效氣喘治療市場

  • 概述
  • 世界其他地區速效氣喘治療市場（按類型）
  • 世界其他地區速效氣喘治療市場（依應用）
  • 中東速效氣喘治療市場
  • 南美洲速效氣喘治療市場
  • 非洲速效氣喘治療市場

第11章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析
    • 競爭對手之間的競爭
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市佔率分析

第12章：機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 按類型分類的成長機會
    • 按應用分類的成長機會
  • 全球速效氣喘治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業的公司簡介

  • Competitive Analysis
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Merck
  • Boehringer Ingelheim

第14章 附錄

  • 圖表目錄
  • 表格列表
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於 Lucintel
  • 詢問

The future of the global quick-acting asthma medicine market looks promising with opportunities in the hospital pharmacy, online pharmacy and retail pharmacy markets. The global quick-acting asthma medicine market is expected to grow with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are the growing need for healthcare, the increasing incidence of chronic diseases, and the rise of biosimilars and generic asthma medications.

  • Lucintel forecasts that, within the type category, tablet is expected to witness higher growth over the forecast period due to more precise dosage control and widespread use..
  • Within the application category, hospital pharmacy is expected to witness the highest growth due to greater control over medication dispensing and inventory management..
  • In terms of region, North America is expected to witness the highest growth over the forecast period due to advanced healthcare infrastructure and higher adoption of pharmaceutical products..

Emerging Trends in the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market is experiencing a series of emerging trends, driven by technological advancements, shifts in healthcare delivery models, and the increasing prevalence of asthma. These trends are reshaping how asthma is treated and managed, offering both challenges and opportunities for industry stakeholders. Below are the key trends that are transforming the market:

  • Inhaler Innovation and Design: Advancements in inhaler technology are significantly improving patient outcomes. Breath-actuated inhalers and portable devices are becoming more common, making it easier for patients to administer their medication correctly and efficiently. These innovations are also contributing to better adherence, as they require less effort from the user. Manufacturers are increasingly focusing on designing inhalers that deliver precise doses while being more user-friendly, particularly for children and the elderly, thus improving the overall asthma management experience.
  • Biosimilars and Generic Medicines: The rise of biosimilars and generic asthma medications is making quick-acting treatments more affordable, especially in emerging markets. With the expiration of patents for certain key asthma drugs, more generic options are entering the market, offering a cost-effective alternative to brand-name medications. This trend is particularly evident in regions like India and China, where cost plays a major role in healthcare accessibility. As a result, more patients can access the medications they need to manage asthma, leading to improved health outcomes.
  • Digital Health Integration: The integration of digital health technologies into asthma management is gaining momentum. Mobile apps, smart inhalers, and remote monitoring devices are enabling patients to track their medication use, asthma symptoms, and triggers in real time. These technologies allow healthcare providers to offer more personalized and responsive care, adjusting treatments based on data collected from patients. As the digital health ecosystem grows, it enhances patient engagement, leading to better asthma management and outcomes.
  • Personalized Medicine: Personalized medicine is becoming an important trend in the quick-acting asthma medicine market, as treatments are increasingly being tailored to individual patient needs. Advances in genetic research and biomarker identification are enabling more precise therapies that consider a patient's specific asthma triggers and underlying genetic factors. This trend is expected to improve the effectiveness of asthma treatments, reduce side effects, and offer more targeted relief for patients who have previously struggled with conventional treatments.
  • Government Initiatives and Public Health Campaigns: Governments worldwide are becoming more involved in asthma management, launching public health campaigns to raise awareness and improve asthma care. Policies that promote early diagnosis, better medication access, and preventive measures are helping to reduce the overall burden of asthma. In addition, global efforts to reduce air pollution are contributing to improved asthma control and fewer exacerbations. These initiatives are especially important in countries with high asthma prevalence, such as China and India, where government support is crucial for enhancing healthcare access.

Emerging trends such as inhaler innovation, biosimilars, digital health integration, personalized medicine, and government initiatives are reshaping the quick-acting asthma medicine market. These trends are improving the accessibility, effectiveness, and affordability of asthma treatments, leading to better patient outcomes and expanding the market's global reach.

Recent Developments in the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market is undergoing significant developments, driven by advancements in drug formulations, inhaler technologies, and regulatory support. These developments are making asthma management more effective and accessible for patients worldwide. Below are five key developments shaping the market:

  • Introduction of New Combination Inhalers: New combination inhalers that deliver both bronchodilators and steroids in a single device are gaining popularity. These inhalers offer a more comprehensive treatment, reducing the need for multiple medications. The availability of combination inhalers allows patients to manage their asthma symptoms more efficiently, leading to better treatment adherence and outcomes.
  • Expansion of Generic and Biosimilar Drugs: The market for quick-acting asthma medications is benefiting from the introduction of generic and biosimilar drugs. As patents for key asthma medications expire, these affordable alternatives are increasing access to essential asthma treatments. Generic and biosimilar medicines help address the growing demand for asthma care, particularly in developing regions where cost is a major barrier.
  • Advancements in Smart Inhalers: Smart inhalers equipped with digital sensors are transforming asthma management. These inhalers track usage and provide real-time feedback to patients and healthcare providers. By helping users adhere to their medication regimen and track symptoms, smart inhalers improve asthma control and reduce hospitalizations. This technology is especially valuable in managing chronic asthma and ensuring timely intervention during exacerbations.
  • Increased Focus on Pediatric Asthma Treatment: There has been a growing emphasis on developing asthma medicines tailored for children. Pediatric asthma treatments, including age-appropriate inhalers and lower-dose formulations, are helping to improve outcomes for young patients. These medications are designed to ensure ease of use and better adherence, particularly for children who may struggle with traditional inhaler devices.
  • Regulatory Support for Fast-track Approvals: Regulatory agencies, including the FDA and EMA, are increasingly supporting the fast-tracking of asthma medicine approvals, particularly for innovative treatments. This support enables quicker access to new therapies, improving treatment options for patients. Streamlined approval processes are crucial in addressing the growing global demand for asthma medicines, allowing for faster market entry of new drugs.

Recent developments in the quick-acting asthma medicine market, such as the introduction of combination inhalers, the rise of biosimilars, smart inhaler technologies, and regulatory support, are reshaping the treatment landscape. These innovations are improving patient care, increasing accessibility, and driving market growth.

Strategic Growth Opportunities in the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market presents several strategic growth opportunities as the demand for effective asthma management grows globally. Key applications, including combination inhalers, digital health integration, and pediatric treatments, provide avenues for expansion. Below are five key growth opportunities across various applications in the market:

  • Combination Inhalers: Combination inhalers, which deliver both bronchodilators and corticosteroids, present a significant growth opportunity in asthma treatment. These inhalers simplify asthma management by reducing the need for multiple medications. The growing demand for more convenient and efficient treatment options, particularly among patients with moderate to severe asthma, is driving the growth of this segment. Manufacturers can capitalize on this trend by developing new combinations that target a broader range of symptoms.
  • Smart Inhalers: Smart inhalers equipped with digital technology are expected to revolutionize asthma management. These devices enable real-time monitoring and tracking of medication adherence, allowing for better management of asthma symptoms. With the integration of mobile apps and sensors, smart inhalers can improve patient engagement and enhance overall treatment effectiveness. As healthcare systems embrace digital health solutions, this segment is poised for rapid growth.
  • Pediatric Asthma Medicines: The pediatric asthma segment offers significant growth potential as the prevalence of asthma among children continues to rise. Developing medications and inhalers tailored for young patients, including age-appropriate doses and easier-to-use devices, is a key area for expansion. Companies focusing on pediatric asthma treatments will benefit from addressing unmet needs in this demographic and improving adherence to treatment protocols.
  • Biosimilars and Generic Medicines: The increasing demand for cost-effective asthma medications presents a growth opportunity for biosimilars and generics. With the expiration of patents for major asthma drugs, the introduction of lower-cost alternatives is expanding market access, particularly in emerging markets. Pharmaceutical companies that invest in biosimilars and generic medicines can tap into a large and growing patient base, driving market penetration in cost-sensitive regions.
  • Global Expansion into Emerging Markets: Emerging markets, particularly in Asia and Africa, present significant growth opportunities for quick-acting asthma medicines. As healthcare infrastructure improves in these regions and asthma awareness increases, demand for effective asthma treatments is rising. Companies that focus on expanding their reach into these markets will benefit from a larger customer base and increased revenue potential.

Strategic growth opportunities in the quick-acting asthma medicine market include the development of combination inhalers, the rise of smart inhalers, pediatric asthma treatments, biosimilars, and global expansion into emerging markets. These opportunities are set to drive market growth and provide innovative solutions for asthma management.

Quick-Acting Asthma Medicine Market Driver and Challenges

The quick-acting asthma medicine market is shaped by various drivers and challenges, driven by technological, economic, and regulatory factors. Understanding these forces is essential for companies looking to capitalize on the growing demand for asthma treatments. Below are the major drivers and challenges impacting the market.

The factors responsible for driving the Quick-acting Asthma Medicine market include:

1. Technological Advancements in Drug Delivery Systems: Technological advancements in inhaler design and drug delivery systems are one of the key drivers for the quick-acting asthma medicine market. The development of more efficient inhalers, such as breath-actuated devices, is improving the accuracy and ease of medication delivery, leading to better patient outcomes and higher adherence to treatment protocols. These innovations are contributing to the market's expansion by offering enhanced solutions for asthma management.

2. Growing Prevalence of Asthma: The increasing prevalence of asthma, especially in urban areas with high pollution levels, is driving demand for quick-acting asthma medications. As more people are diagnosed with asthma, there is a higher need for effective and fast-acting treatments. The rising asthma rates, particularly in developing countries, are contributing to the growth of the asthma medicine market, as more patients seek immediate relief options.

3. Rising Healthcare Access and Awareness: Improved access to healthcare and greater awareness of asthma management are significant drivers for the market. As healthcare systems in emerging markets like India and China improve, more patients are able to access quick-acting asthma medicines. Public health campaigns and education on asthma management are also leading to better recognition and treatment of the condition, further fueling market growth.

4. Government Initiatives and Regulatory Support: Government initiatives to improve asthma care, along with favorable regulatory support for new asthma treatments, are playing a crucial role in the market's expansion. Regulatory agencies are expediting the approval process for innovative asthma medications, while government-funded health programs are improving patient access to effective treatments.

5. Investment in Research and Development: Increased investment in asthma-related research and development is driving innovation in the market. Pharmaceutical companies are working on new formulations, combination therapies, and smart inhalers, which are expected to improve treatment outcomes and reduce asthma-related hospitalizations. The continued focus on R&D will likely lead to more advanced and effective treatments for asthma.

Challenges in the Quick-acting Asthma Medicine market are:

1. High Cost of Treatment: The high cost of asthma medications, especially newer combination inhalers and biologics, remains a significant challenge. Although quick-acting medications are essential for managing asthma, their cost can limit access for many patients, particularly in low- and middle-income countries. Addressing this cost barrier is crucial for improving accessibility and patient adherence.

2. Regulatory Barriers: Despite regulatory support for new treatments, regulatory barriers and lengthy approval processes for asthma medicines remain a challenge. These hurdles can delay the availability of innovative treatments, hindering market growth and limiting patient access to new therapies. Companies must navigate these regulatory challenges to bring new products to market efficiently.

3. Side Effects and Safety Concerns: Safety concerns, particularly the side effects of certain asthma medications, pose challenges to market growth. While quick-acting medications offer immediate relief, they can cause side effects such as tremors or tachycardia. The need for better safety profiles and more personalized treatments is critical to ensuring patient safety and improving treatment compliance.

The quick-acting asthma medicine market is driven by technological innovations, increased asthma prevalence, rising healthcare access, and regulatory support. However, challenges such as high treatment costs, regulatory barriers, and safety concerns must be addressed to ensure continued growth and broader access to effective asthma treatments.

List of Quick-Acting Asthma Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies quick-acting asthma medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the quick-acting asthma medicine companies profiled in this report include-

  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Merck
  • Boehringer Ingelheim

Quick-Acting Asthma Medicine Market by Segment

The study includes a forecast for the global quick-acting asthma medicine market by type, application, and region.

Quick-Acting Asthma Medicine Market by Type [Value from 2019 to 2031]:

  • Tablet
  • Spray

Quick-Acting Asthma Medicine Market by Application [Value from 2019 to 2031]:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Quick-Acting Asthma Medicine Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market is experiencing significant developments due to ongoing innovation, increased healthcare access, and growing asthma prevalence across the globe. These medicines are designed to relieve asthma symptoms promptly and effectively, making them essential in managing acute attacks. In key markets such as the United States, China, Germany, India, and Japan, advancements in drug formulations, inhaler technologies, and regulatory frameworks are reshaping the market landscape. Below is an overview of recent developments in these regions, highlighting important trends, regulatory changes, and emerging treatment options.

  • United States: In the United States, the quick-acting asthma medicine market has seen significant growth with the introduction of new inhalers and combination therapies. Medications like albuterol and levalbuterol, along with new combination products such as the EpiPen for emergency relief, are driving the market. The focus on innovative inhaler designs, such as breath-actuated devices, is enhancing the user experience, making treatment more efficient and effective. Additionally, regulatory support from the FDA for novel delivery systems is further expanding treatment options, providing patients with more personalized and accessible solutions for managing asthma.
  • China: In China, the quick-acting asthma medicine market is expanding rapidly due to rising air pollution, an increasing incidence of asthma, and greater healthcare access. Local pharmaceutical companies are advancing the development of generic asthma medications, making quick-acting inhalers more affordable. Recent regulatory changes have streamlined the approval process for asthma drugs, improving market availability. With an aging population and increased urbanization, demand for asthma medications is expected to continue to rise, while government policies are increasingly focused on improving public health infrastructure and ensuring timely access to essential asthma treatments.
  • Germany: Germany is a key player in the European quick-acting asthma medicine market, where new inhaler technologies and combination therapies are becoming more popular. Companies are developing inhalers that deliver more accurate dosages with less user effort, thus improving treatment adherence. Recent collaborations between pharmaceutical companies and healthcare providers have led to more efficient asthma management strategies. Germany's robust healthcare system and regulatory support for innovative medicines have fostered a favorable environment for the growth of new treatments and improved delivery mechanisms, contributing to a larger share of the European asthma market.
  • India: India is witnessing a surge in demand for quick-acting asthma medicines due to the rising prevalence of respiratory conditions, exacerbated by pollution and smoking. The market is seeing an increase in affordable inhalers, with both local and international companies introducing cost-effective solutions for asthma patients. Regulatory reforms and increased government funding for public health initiatives have made asthma treatments more accessible to the Indian population. Additionally, local manufacturers are working on improving inhaler design and drug formulations to offer better patient outcomes while addressing affordability concerns in the country's growing healthcare sector.
  • Japan: Japan's quick-acting asthma medicine market has been expanding with innovations in inhaler technologies and advancements in precision medicines. Japanese pharmaceutical companies are developing drugs that not only offer fast relief but also minimize side effects, such as those found in combination inhalers. Regulatory approvals for new treatments have been quick, contributing to a more diverse and effective market for asthma medications. The aging population in Japan is driving the demand for effective and user-friendly asthma treatments, while recent policy efforts are aimed at improving healthcare accessibility, ensuring timely delivery of medications to asthma patients across the country.

Features of the Global Quick-Acting Asthma Medicine Market

  • Market Size Estimates: Quick-acting asthma medicine market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Quick-acting asthma medicine market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Quick-acting asthma medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the quick-acting asthma medicine market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the quick-acting asthma medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the quick-acting asthma medicine market by type (tablet and spray), application (hospital pharmacy, online pharmacy, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Quick-Acting Asthma Medicine Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Tablet: Trends and Forecast (2019-2031)
  • 4.4 Spray: Trends and Forecast (2019-2031)

5. Global Quick-Acting Asthma Medicine Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital Pharmacy: Trends and Forecast (2019-2031)
  • 5.4 Online Pharmacy: Trends and Forecast (2019-2031)
  • 5.5 Retail Pharmacy: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Quick-Acting Asthma Medicine Market by Region

7. North American Quick-Acting Asthma Medicine Market

  • 7.1 Overview
  • 7.2 North American Quick-Acting Asthma Medicine Market by type
  • 7.3 North American Quick-Acting Asthma Medicine Market by application
  • 7.4 United States Quick-Acting Asthma Medicine Market
  • 7.5 Mexican Quick-Acting Asthma Medicine Market
  • 7.6 Canadian Quick-Acting Asthma Medicine Market

8. European Quick-Acting Asthma Medicine Market

  • 8.1 Overview
  • 8.2 European Quick-Acting Asthma Medicine Market by type
  • 8.3 European Quick-Acting Asthma Medicine Market by application
  • 8.4 German Quick-Acting Asthma Medicine Market
  • 8.5 French Quick-Acting Asthma Medicine Market
  • 8.6 Spanish Quick-Acting Asthma Medicine Market
  • 8.7 Italian Quick-Acting Asthma Medicine Market
  • 8.8 United Kingdom Quick-Acting Asthma Medicine Market

9. APAC Quick-Acting Asthma Medicine Market

  • 9.1 Overview
  • 9.2 APAC Quick-Acting Asthma Medicine Market by type
  • 9.3 APAC Quick-Acting Asthma Medicine Market by application
  • 9.4 Japanese Quick-Acting Asthma Medicine Market
  • 9.5 Indian Quick-Acting Asthma Medicine Market
  • 9.6 Chinese Quick-Acting Asthma Medicine Market
  • 9.7 South Korean Quick-Acting Asthma Medicine Market
  • 9.8 Indonesian Quick-Acting Asthma Medicine Market

10. ROW Quick-Acting Asthma Medicine Market

  • 10.1 Overview
  • 10.2 ROW Quick-Acting Asthma Medicine Market by type
  • 10.3 ROW Quick-Acting Asthma Medicine Market by application
  • 10.4 Middle Eastern Quick-Acting Asthma Medicine Market
  • 10.5 South American Quick-Acting Asthma Medicine Market
  • 10.6 African Quick-Acting Asthma Medicine Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Quick-Acting Asthma Medicine Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Pfizer
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 GlaxoSmithKline
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Novartis
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Merck
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Boehringer Ingelheim
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Quick-Acting Asthma Medicine Market
  • Figure 2.1: Usage of Quick-Acting Asthma Medicine Market
  • Figure 2.2: Classification of the Global Quick-Acting Asthma Medicine Market
  • Figure 2.3: Supply Chain of the Global Quick-Acting Asthma Medicine Market
  • Figure 3.1: Driver and Challenges of the Quick-Acting Asthma Medicine Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Quick-Acting Asthma Medicine Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Quick-Acting Asthma Medicine Market ($B) by Type
  • Figure 4.3: Forecast for the Global Quick-Acting Asthma Medicine Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Tablet in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Spray in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.1: Global Quick-Acting Asthma Medicine Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Quick-Acting Asthma Medicine Market ($B) by Application
  • Figure 5.3: Forecast for the Global Quick-Acting Asthma Medicine Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Online Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Retail Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 6.1: Trends of the Global Quick-Acting Asthma Medicine Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Quick-Acting Asthma Medicine Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 7.3: Forecast for the North American Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 7.4: North American Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 7.6: Forecast for the North American Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.1: European Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 8.3: Forecast for the European Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 8.4: European Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 8.6: Forecast for the European Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.1: APAC Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 9.3: Forecast for the APAC Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 9.4: APAC Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 9.6: Forecast for the APAC Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 10.1: ROW Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 10.3: Forecast for the ROW Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 10.4: ROW Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 10.6: Forecast for the ROW Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Quick-Acting Asthma Medicine Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Quick-Acting Asthma Medicine Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Quick-Acting Asthma Medicine Market by Type
  • Figure 12.2: Growth Opportunities for the Global Quick-Acting Asthma Medicine Market by Application
  • Figure 12.3: Growth Opportunities for the Global Quick-Acting Asthma Medicine Market by Region
  • Figure 12.4: Emerging Trends in the Global Quick-Acting Asthma Medicine Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Quick-Acting Asthma Medicine Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Quick-Acting Asthma Medicine Market by Region
  • Table 1.3: Global Quick-Acting Asthma Medicine Market Parameters and Attributes
  • Table 3.1: Trends of the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 3.2: Forecast for the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Quick-Acting Asthma Medicine Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 4.4: Trends of Tablet in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 4.5: Forecast for Tablet in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 4.6: Trends of Spray in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 4.7: Forecast for Spray in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Quick-Acting Asthma Medicine Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.4: Trends of Hospital Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.5: Forecast for Hospital Pharmacy in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.6: Trends of Online Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.7: Forecast for Online Pharmacy in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.8: Trends of Retail Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.9: Forecast for Retail Pharmacy in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.1: Trends of the North American Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 7.2: Forecast for the North American Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various type in the North American Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various type in the North American Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various application in the North American Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various application in the North American Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.1: Trends of the European Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 8.2: Forecast for the European Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various type in the European Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various type in the European Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various application in the European Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various application in the European Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.1: Trends of the APAC Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 9.2: Forecast for the APAC Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various type in the APAC Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various type in the APAC Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various application in the APAC Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various application in the APAC Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 10.1: Trends of the ROW Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 10.2: Forecast for the ROW Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various type in the ROW Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various type in the ROW Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various application in the ROW Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various application in the ROW Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 11.1: Product Mapping of Quick-Acting Asthma Medicine Suppliers Based on Segments
  • Table 11.2: Operational Integration of Quick-Acting Asthma Medicine Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Quick-Acting Asthma Medicine Revenue
  • Table 12.1: New Product Launches by Major Quick-Acting Asthma Medicine Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Quick-Acting Asthma Medicine Market